Journal article Open Access

EFFICACY AND SAFETY OF AZILSARTAN COMPARED WITH TELMISARTAN IN HYPERTENSIVE PATIENTS.

Lenka D.N.; Routray S.N.


JSON Export

{
  "files": [
    {
      "links": {
        "self": "https://zenodo.org/api/files/d0f86ba9-962d-441e-9b78-efe0882d33fc/21.pdf"
      }, 
      "checksum": "md5:1ff3002e64bca525ed6bb384e0ce7d2b", 
      "bucket": "d0f86ba9-962d-441e-9b78-efe0882d33fc", 
      "key": "21.pdf", 
      "type": "pdf", 
      "size": 353086
    }
  ], 
  "owners": [
    40781
  ], 
  "doi": "10.5281/zenodo.3365128", 
  "stats": {
    "version_unique_downloads": 8.0, 
    "unique_views": 22.0, 
    "views": 22.0, 
    "version_views": 22.0, 
    "unique_downloads": 8.0, 
    "version_unique_views": 22.0, 
    "volume": 3177774.0, 
    "version_downloads": 9.0, 
    "downloads": 9.0, 
    "version_volume": 3177774.0
  }, 
  "links": {
    "doi": "https://doi.org/10.5281/zenodo.3365128", 
    "conceptdoi": "https://doi.org/10.5281/zenodo.3365127", 
    "bucket": "https://zenodo.org/api/files/d0f86ba9-962d-441e-9b78-efe0882d33fc", 
    "conceptbadge": "https://zenodo.org/badge/doi/10.5281/zenodo.3365127.svg", 
    "html": "https://zenodo.org/record/3365128", 
    "latest_html": "https://zenodo.org/record/3365128", 
    "badge": "https://zenodo.org/badge/doi/10.5281/zenodo.3365128.svg", 
    "latest": "https://zenodo.org/api/records/3365128"
  }, 
  "conceptdoi": "10.5281/zenodo.3365127", 
  "created": "2019-08-10T08:32:08.458524+00:00", 
  "updated": "2020-01-20T15:55:03.012487+00:00", 
  "conceptrecid": "3365127", 
  "revision": 4, 
  "id": 3365128, 
  "metadata": {
    "access_right_category": "success", 
    "doi": "10.5281/zenodo.3365128", 
    "description": "<p>Objective: Angiotensive receptor blockers (ARBs) are very potent antihypertensive agents , Telmisartan being the prototype and most widely used.This study was undertaken to compare the efficacy and safety of Azilsartan a new ARB with Telmisartan. Material and methods : This prospective study was carried out in patients attending the Department of Medicine, SCB Medical college, Cuttack. Patients with newly diagnosed with stage I-II essential hypertension of either sex within the age group of 18?65 years with blood pressure of &ge;140/90 mmHg were included in the study. Severe hypertension &gt;180/110 mm of Hg, hypersensitivity to ARBs, secondary hypertension with any other etiology, pregnant women, history of Drug/ Alcohol abuse, cardiac arrhythmias were excluded. Patients who gave consent for the study were divided into 2 random groups 1 and 2 ? the first received azilsartan and the second received telmisartan. Point of control was defined as blood pressure&lt;140/90 mm of Hg after initiation of therapy. Results : 180 patients were randomized into two groups. Out of 90 patients included in group 1 who received azilsartan, 4 lost for follow up. Out of 90 patients included in group 2 who received telmisartan, 5 lost for follow up. There was no significant difference between the two drugs in both mean systolic and diastolic blood pressure at 24hrs, 1 month and 3 months and 6 months. Mean diastolic blood pressure at 24 hrs was reduced more with telmisartan compared to azilsartan which is significant. Hypotension related adverse effects occurred in 3% of the patients in azilsartan group while it occurred in 8% of them in telmisartan group. Conclusion: Azilsartan is an effective blood pressure lowering drug with its safety and efficacy comparable to that of telmisartan.</p>", 
    "license": {
      "id": "CC-BY-4.0"
    }, 
    "title": "EFFICACY AND SAFETY OF AZILSARTAN COMPARED WITH TELMISARTAN IN HYPERTENSIVE PATIENTS.", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "3365127"
          }, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "3365128"
          }
        }
      ]
    }, 
    "keywords": [
      "Blood Pressure Azilsartan Telmisartan."
    ], 
    "publication_date": "2019-07-01", 
    "creators": [
      {
        "affiliation": "Senior Resident, Dept. of Cardiology, S.C.B.Medical College. Cuttack, Odisha, India.", 
        "name": "Lenka D.N."
      }, 
      {
        "affiliation": "Professor, Dept. of Cardiology, S.C.B.Medical College. Cuttack, Odisha, India.", 
        "name": "Routray S.N."
      }
    ], 
    "access_right": "open", 
    "resource_type": {
      "subtype": "article", 
      "type": "publication", 
      "title": "Journal article"
    }, 
    "related_identifiers": [
      {
        "scheme": "doi", 
        "identifier": "10.5281/zenodo.3365127", 
        "relation": "isVersionOf"
      }
    ]
  }
}
22
9
views
downloads
All versions This version
Views 2222
Downloads 99
Data volume 3.2 MB3.2 MB
Unique views 2222
Unique downloads 88

Share

Cite as